Department of Molecular Microbiology, Washington University Medical School, St. Louis, Missouri, USA.
Department of Molecular and Cellular Biology, University of Guelph, Ontario, Canada.
mBio. 2023 Feb 28;14(1):e0338422. doi: 10.1128/mbio.03384-22. Epub 2023 Feb 7.
The fungal pathogen Cryptococcus neoformans is distinguished by a cell-wall-anchored polysaccharide capsule that is critical for virulence. Biogenesis of both cell wall and capsule relies on the secretory pathway. Protein secretion begins with polypeptide translocation across the endoplasmic reticulum (ER) membrane through a highly conserved channel formed by three proteins: Sec61, Sbh1, and Sss1. Sbh1, the most divergent, contains multiple phosphorylation sites, which may allow it to regulate entry into the secretory pathway in a species- and protein-specific manner. Absence of causes a cell-wall defect in both Saccharomyces cerevisiae and C. neoformans, although other phenotypes differ. Notably, proteomic analysis showed that when cryptococci are grown in conditions that mimic aspects of the mammalian host environment (tissue culture medium, 37°C, 5% CO), a set of secretory and transmembrane proteins is upregulated in wild-type, but not in mutant cells. The Sbh1-dependent proteins show specific features of their ER targeting sequences that likely cause them to transit less efficiently into the secretory pathway. Many also act in cell-wall biogenesis, while several are known virulence factors. Consistent with these observations, the C. neoformans mutant is avirulent in a mouse infection model. We conclude that, in the context of conditions encountered during infection, Sbh1 controls the entry of virulence factors into the secretory pathway of C. neoformans, and thereby regulates fungal pathogenicity. Cryptococcus neoformans is a yeast that causes almost 200,000 deaths worldwide each year, mainly of immunocompromised individuals. The surface structures of this pathogen, a protective cell wall surrounded by a polysaccharide capsule, are made and maintained by proteins that are synthesized inside the cell and travel outwards through the secretory pathway. A protein called Sbh1 is part of the machinery that determines which polypeptides enter this export pathway. We found that when Sbh1 is absent, both C. neoformans and the model yeast S. cerevisiae show cell-wall defects. Lack of Sbh1 also changes the pattern of secretion of both transmembrane and soluble proteins, in a manner that depends on characteristics of their sequences. Notably, multiple proteins that are normally upregulated in conditions similar to those encountered during infection, including several needed for cryptococcal virulence, are no longer increased. Sbh1 thereby regulates the ability of this important pathogen to cause disease.
新型隐球菌是一种真菌病原体,其特征是细胞壁锚定的多糖荚膜,这对于其毒力至关重要。细胞壁和荚膜的生物发生都依赖于分泌途径。蛋白质分泌始于穿过内质网 (ER) 膜的多肽易位,该过程通过由三个蛋白质组成的高度保守通道进行:Sec61、Sbh1 和 Sss1。Sbh1 是最具差异的,它包含多个磷酸化位点,这可能使其以物种和蛋白质特异性的方式调节进入分泌途径。 在酿酒酵母和新型隐球菌中, 缺失都会导致细胞壁缺陷,尽管其他表型不同。值得注意的是,蛋白质组学分析表明,当隐球菌在模拟哺乳动物宿主环境(组织培养基,37°C,5% CO)的条件下生长时,一组分泌和跨膜蛋白在野生型中上调,但在 突变细胞中没有。依赖 Sbh1 的蛋白质具有其 ER 靶向序列的特定特征,这可能导致它们不太有效地进入分泌途径。许多蛋白质也参与细胞壁生物发生,而一些则是已知的毒力因子。与这些观察结果一致,新型隐球菌 突变体在小鼠感染模型中没有毒力。我们得出的结论是,在感染过程中遇到的条件下,Sbh1 控制着毒力因子进入新型隐球菌分泌途径的进入,从而调节真菌的致病性。新型隐球菌是一种导致全球每年近 200,000 人死亡的酵母,主要发生在免疫功能低下的个体中。该病原体的表面结构是由多糖荚膜包围的保护性细胞壁组成,这些结构是由在细胞内合成并通过分泌途径向外运输的蛋白质制成和维持的。一种称为 Sbh1 的蛋白质是决定哪些多肽进入这种外排途径的机制的一部分。我们发现,当 Sbh1 缺失时,新型隐球菌和模型酵母酿酒酵母都表现出细胞壁缺陷。Sbh1 的缺失也以依赖于其序列特征的方式改变跨膜和可溶性蛋白的分泌模式。值得注意的是,在类似于感染过程中遇到的条件下通常上调的多种蛋白质,包括新型隐球菌毒力所需的多种蛋白质,不再增加。因此,Sbh1 调节这种重要病原体引起疾病的能力。